NantKwest & ImmunityBio Transaction

December 21, 2020

Webcast and Presentation

ImmunityBio and NantKwest Transaction Announcement
Investor Conference Call (8:30 am Eastern, December 20, 2020)

For the audio recording of the presentation, please see below.

To access the Investor presentation, please click the link below.

Press Releases & Pipeline

ImmunityBio and NantKwest to Merge, Creating a Leading
Immunotherapy and Cell Therapy Company

Consolidated NantKwest and ImmunityBio Pipeline

To enlarge, please click the image below.

NK IB logos
ImmunityBio logo
+1 310-883-1300
9920 Jefferson Blvd. Culver City CA 90232